GL1X · GenesisL1 explorer

MolNFT v1 · #102555 · protein

Constructing tailored isoprenoid products by structure-guided modification of geranylgeranyl reductase.

4OPC · Conserved archaeal protein: “Constructing tailored isoprenoid products by structure-guided modification of geranylgeranyl reductase.”. X-ray diffraction, 2 ligands (FDA, PGT), 3 pockets (best druggability 0.87). MolNFT v1 #102555 on…

PDB
4OPC
Type
protein
Length
452 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Conserved archaeal protein
EC
1.3.1.83
UniProt
Q4JA33
Ligands
FDA, PGT
Pockets
3 · best druggability 0.87

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AConserved archaeal protein (EC 1.3.1.83)protein45241% helix, 26% strandQ4JA33

Ligands and binding sites

  • FDA · Dihydroflavine-adenine dinucleotide · ligand · chains A
  • PGT · (1S)-2-{[{[(2R)-2,3-dihydroxypropyl]oxy}(hydroxy) phosphoryl]oxy}-1-[(palmitoyloxy)methyl]ethyl stearate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110810.870.88110FDA, PGT
2920.380.7617empty
3710.330.7616empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4OPC · Constructing tailored isoprenoid products by structure-guided modification of… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q4JA33 · AlphaFold monomer V2.0 prediction for digeranylgeranylglycerophospholipid reductase… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.